Birdwatch Note
2023-09-15 20:49:30 UTC - NOT_MISLEADING
NNN. There is broad evidence that Ivermectin has positive effects when used for Covid-19 treatment: https://c19ivm.org/
Written by 2C76C82EB0F264BCA285B41D04C2707655CECBD1FDCE806E1AD63877872D0062
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1702763448466018379
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1702786745190797630
- noteId - 1702786745190797630
- participantId -
- noteAuthorParticipantId - 2C76C82EB0F264BCA285B41D04C2707655CECBD1FDCE806E1AD63877872D0062 Participant Details
- createdAtMillis - 1694810970959
- tweetId - 1702763448466018379
- classification - NOT_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 1
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 1
- trustworthySources - 1
- summary
- NNN. There is broad evidence that Ivermectin has positive effects when used for Covid-19 treatment: https://c19ivm.org/
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2023-09-15 20:49:30 UTC (1694810970959) |
1969-12-31 23:59:59 UTC (-1) |
2023-09-16 02:12:36 UTC (1694830356504) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
rated at | rated by | |
2023-09-15 18:40:36 -0500 | Rating Details | |
2023-09-15 18:20:25 -0500 | Rating Details | |
2023-09-15 18:15:14 -0500 | Rating Details | |
2023-09-15 17:45:07 -0500 | Rating Details | |
2023-09-15 17:29:35 -0500 | Rating Details | |
2023-09-15 17:23:40 -0500 | Rating Details | |
2023-09-15 17:02:05 -0500 | Rating Details | |
2023-09-15 17:02:04 -0500 | Rating Details | |
2023-09-15 16:58:17 -0500 | Rating Details | |
2023-09-15 16:47:15 -0500 | Rating Details | |
2023-09-15 16:35:04 -0500 | Rating Details | |
2023-09-15 16:33:10 -0500 | Rating Details | |
2023-09-15 16:31:12 -0500 | Rating Details | |
2023-09-15 16:27:38 -0500 | Rating Details | |
2023-09-15 16:09:14 -0500 | Rating Details | |
2023-09-15 16:06:11 -0500 | Rating Details | |
2023-09-15 15:58:11 -0500 | Rating Details | |
2023-09-16 12:40:46 -0500 | Rating Details | |
2023-09-16 11:32:05 -0500 | Rating Details | |
2023-09-16 09:18:10 -0500 | Rating Details | |
2023-09-16 07:51:27 -0500 | Rating Details | |
2023-09-16 04:13:23 -0500 | Rating Details | |
2023-09-16 03:40:36 -0500 | Rating Details | |
2023-09-16 02:19:49 -0500 | Rating Details | |
2023-09-16 01:24:57 -0500 | Rating Details | |
2023-09-16 00:50:52 -0500 | Rating Details | |
2023-09-16 00:04:22 -0500 | Rating Details | |
2023-09-15 23:17:58 -0500 | Rating Details | |
2023-09-15 22:54:10 -0500 | Rating Details | |
2023-09-15 22:45:07 -0500 | Rating Details | |
2023-09-15 21:40:48 -0500 | Rating Details | |
2023-09-15 21:39:44 -0500 | Rating Details | |
2023-09-15 21:26:29 -0500 | Rating Details | |
2023-09-27 01:55:40 -0500 | Rating Details |